We assessed the effect of the previously uncovered gap junction protein alpha 8 (Gja8) mutation present in spontaneously hypertensive rat -dominant cataract (SHR-Dca) strain on blood pressure, metabolic profile, and heart and renal transcriptomes.
Introduction
Hypertension has a high prevalence globally and represents a major risk factor for coronary heart disease, kidney failure, and stroke (Mozaffarian et al. 2016) . Elucidation of the genes responsible for essential hypertension is, compared with other complex diseases, particularly challenging in spite of rather promising results stemming from recent large scale genome-wide association and exome sequencing studies (Padmanabhan et al. 2015) . The identified genetic risk variants explain a relatively small portion of blood pressure variations, and therefore their clinical use remains limited.
Genetically defined animal models remain valuable tools for the identification of genes and pathways underlying complex cardiovascular traits, even in the era of systems biology (Civelek and Lusis 2014) . The spontaneously hypertensive rat (SHR) is the Vol. 66 most widely studied animal model of essential hypertension and has proven to be a highly valuable tool for deciphering the genomic, epigenomic, and physiological aspects of blood pressure control (Pravenec et al. 2014) .
We previously identified a new connexin 50 mutation, L7Q (Liska et al. 2008) , that arose spontaneously in the SHR/OlaIpcv (Rat Genome Database (RGD) ID: 631848; (Shimoyama et al. 2015) inbred rat leading to microphthalmia and cataract formation in thus created coisogenic rat strain SHR-Gja8 m1Cub (SHR-Dca; RGD ID: 2293729).
Connexins are a family of transmembrane proteins that form intercellular gap junction channels. The family comprises 21 isoforms in rodents and humans (Saez and Leybaert 2014) . There is considerable homology between the different connexins in humans, rats, and mice (Oyamada et al. 2005) .
Several human genetic disorders caused by spontaneous mutations in connexin genes (Kelly et al. 2015) as well as knockout mouse disease models have been described to date (Reaume et al. 1995 , White et al. 1998 . Besides the lens of the eye as its major expression site (Beyer and Berthoud 2014), connexin 50 was also found to be present in mouse and rabbit retinae (O'Brien et al. 2006) , in human and rat kidney (Silverstein et al. 2003) , in rat cornea (Laux-Fenton et al. 2003) , and in chromaffin cells of human adrenals (Willenberg et al. 2006) .
In the present study, we used the coisogenic pair of rat inbred strains SHR and SHR-Dca, differing only in the identified point mutation (Liska et al. 2008) , to examine the impact of connexin 50 on hemodynamic and metabolic parameters that make the SHR strain an experimental model of essential hypertension (Okamoto and Aoki 1963) and, in a broader sense, of metabolic syndrome (Pravenec et al. 2014) .
Methods

Ethical statement
The study was conducted in accordance with the Animal Protection Law of the Czech Republic and was approved by the ethical committee of the First Faculty of Medicine, Charles University in Prague. Animals were held under temperature and humidity controlled conditions on a 12-h light/dark cycle. At all times, the animals had free access to food and water.
Rat strains
The SHR (RGD ID: 631848) is one of the most widely used models of essential hypertension (Langley et al. 2013 ) and disturbances of carbohydrate and lipid metabolism (Aitman et al. 1997) . The SHR inbred colony in Prague was originally obtained from the US National Institutes of Health over 30 years ago, and since then it has been maintained by brother × sister mating at the Institute of Biology and Medical Genetics. SHR-Dca (RGD ID: 2293729) originated from a spontaneous mutation within our inbred SHR/OlaIpcv colony (Liska et al. 2008 ) and has been maintained at the Institute of Biology and Medical Genetics since.
Metabolic measurements
Adult, standard chow-fed males (4 months of age) of both strains (n=8 and n=9 for SHR and SHR-Dca, respectively) were used for metabolic measurements. The oral glucose tolerance test was performed after an overnight fast and the blood samples taken for glycemic determination (Ascensia Elite Blood Glucose Meter; Bayer HealthCare, Mishawaka, IN, USA; validated by Institute of Clinical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine) were obtained from the tail vein at intervals of 0, 30, 60, 120, and 180 min after the intragastric glucose administration to conscious rats (3 g/kg body weight, 30 % aqueous solution). The lipidemic profile (cholesterol and triacylglycerol blood concentrations in 20 lipoprotein fractions, glycerol level, and chylomicron, very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) particle sizes) was assessed using high performance liquid chromatography, as described previously (Sedova et al. 2012 , Usui et al. 2002 . For determination of triacylglycerol content in the liver, tissue was powdered under liquid N 2 and extracted over 16 h in chloroform:methanol after which 2 % KH 2 PO 4 was added and the solution centrifuged. The organic phase was removed and evaporated under N 2 . The resulting pellet was dissolved in isopropyl alcohol, and the triacylglycerols content was determined by enzymatic assay (ErbaLachema, Brno, Czech Republic).
Basal-and insulin-stimulated glycogen synthesis in muscle, and glucose utilization in isolated white adipose tissue
Diaphragmatic muscles were incubated ex vivo for 2 h in 95 % O 2 + 5 % CO 2 in Krebs-Ringer bicarbonate buffer, (pH 7.4) containing 0.1 µCi/ml of [U-14 C] glucose, 5 mmol/l of unlabeled glucose, and 2.5 mg/ml of bovine serum albumin (Fraction V; Sigma-Aldrich, St. Louis, MO, USA), with or without 250 µU/ml insulin. Glycogen was extracted, and insulin stimulated incorporation of glucose into glycogen was determined. Pieces of epididymal fat were rapidly dissected and incubated for 2 h in Krebs-Ringer bicarbonate buffer with 5 mmol/l glucose, 0.1 µCi [U-14 C] glucose/ml (UVVR, Prague, Czech Republic) and 2 % bovine serum albumin, gaseous phase 95 % O 2 and 5 % CO 2 in the presence (250 µU/ml) or absence of insulin in incubation media. All incubations were performed at 37 °C in sealed vials in a shaking water bath. We estimated incorporation of [U-14 C] glucose into neutral lipids. Briefly, fat was removed from incubation medium, rinsed in saline, and immediately placed into chloroform. Pieces of tissue were dissolved using a Teflon pestle homogenizer, methanol was added (chloroform:methanol 2:1), and lipids were extracted at 4 °C overnight. The remaining tissue was removed, KH 2 PO 4 was added, and the clear extract was taken for further analysis. An aliquot was evaporated, reconstituted in scintillation liquid, and radioactivity measured by scintillation counting. Incremental glucose utilization was calculated as the difference between the insulin-stimulated and basal incorporation of glucose into neutral lipids.
Blood pressure measurement
This was performed using a group of animals distinct to those used for metabolic studies. Rats were fed standard chow and had free access to food and water. Arterial blood pressure was measured continuously by radiotelemetry in conscious, unrestrained 12-week-old male rats (n=8 for each strain). All rats were allowed to recover for at least 7 days after surgical implantation of radiotelemetry transducers before the start of blood pressure recordings. Pulsatile pressure was recorded in 10-second bursts every 10 min throughout the day, and 12-hour averages for systolic and diastolic arterial blood pressure were calculated for each rat for a period of 21 days. Results from each rat in the same group were averaged to obtain the group mean.
Immunohistochemistry
At the end of the experiments, the left kidney, heart, aorta, vena cava inferior, liver, lungs, and testes were quickly removed and snap frozen in liquid N 2 . Threemicrometer-thick cryostat sections were used for immunohistochemistry. Slides were fixed in 4 % paraformaldehyde for 2 min at 4 °C. Sections were immunostained with polyclonal rabbit connexin 50 antibody (Santa Cruz, Dallas, USA) diluted 1:500 in ChemMate antibody diluent (Dako, Cytomation, Glostrup, Denmark). Primary antibody was performed overnight at 4 °C. An Envision kit (Dako, Cytomation, Glostrup, Denmark) was used to visualize sections incubated with the primary antibody. Chromogen 3,3-diaminobenzidine was applied to all sections and counterstaining was performed with Mayer's hematoxylin. Optimal staining conditions of any given antibody were determined using appropriate positive and negative controls. Slides were analyzed on a Nikon ECLIPSE Ni-E (Nikon, Tokyo, Japan). All immunostainings were confirmed using at least five rats in each group.
Glomerular size assessment
Right kidney and parts of other organs (heart, aorta, vena cava inferior, liver, lungs, and testes) were fixed in 4 % buffered formaldehyde, dehydrated, and embedded. Five-micrometer-thick paraffin sections were stained with hematoxylin/eosin and periodic acid-Schiff reaction and examined using a Nikon ECLIPSE Ni-E light microscope (Nikon). Slides were evaluated in a blind fashion.
Morphometric evaluation of glomerular volume was made with the same kidney sections that were examined for morphological changes using the method validated by Lane et al. (1992) and employed in our recent studies (Certikova Chabova et al. 2010) using Nikon NIS-Elements AR 3.1 morphometric program (Nikon). Briefly, this method involves determination of mean glomerular profile area and calculation of mean glomerular volume from the following formula: glomerular volume = area 1.5 × 1.38/1.01, where 1.38 is β, the shape coefficient for a sphere, and 1.01 is the size distribution coefficient 0 assuming a 10 % coefficient of variation.
Transcriptomic profiling and quantitative real-time polymerase chain reaction (PCR)
Affymetrix GeneChip® Rat Exon 1.0 ST array was used to determine transcriptomic characteristics of SHR and coisogenic strain SHR-Dca. We extracted total RNA from the kidneys and hearts of 4-month-old males of both strains (n=6 per strain) using phenol-chloroform and purified using a RNeasy Mini kit (Qiagen, Valencia, CA, USA) in accordance with the manufacturer's protocol. The quality of total RNA was verified using an Agilent 2100 Bioanalyzer system. Double-stranded complementary DNA (cDNA) was synthesized from total RNA. Labeled Vol. 66 and fragmented cDNA was pooled for each strain (SHR, SHR-Dca) and tissue (heart, kidney) and hybridized to Affymetrix GeneChip® Rat Exon 1.0 ST arrays in triplicate (three pools per strain and tissue, each containing RNA from two animals, i.e. a total of 12 arrays). The whole hybridization procedure including DNA adjustment was performed according to the protocol recommended by Affymetrix. The microarray data were deposited in ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-4542. To validate microarray gene expression data, quantitative real-time PCR (SYBR-Green) was used. Total RNA (2 µg) was reverse-transcribed with random primers using a SuperScript® VILO™ cDNA synthesis kit (Invitrogen, Carlsbad, CA, USA). Primers were designed using Primer3 (Untergasser et al. 2012 ) and synthesized by Integrated DNA Technologies (Coralville, IA, USA). Real-time PCR was performed in quadruplicate with EXPRESS SYBR® GreenER™ qPCR SuperMix with a Premixed ROX kit according to the manufacturer's protocol (Invitrogen) using an Applied Biosystems 7900HT Fast real-time PCR System. Results were analyzed using the Pfaffl analysis method (Pfaffl, 2001 ) with the reference genes peptidylprolyl isomerase B and 18S.
Statistical and pathway analyses
Metabolic and morphometric data were compared using the unpaired Student's t-test. For transcriptomic data, after evaluation of hybridization, quality control, and the data normalization by robust multi-array analysis, gene expression was compared between the SHR and the SHR-Dca strains using PARTEK Genomics Suite 6.6 (Partek, Inc., Chesterfield, MO, USA). Transcripts found to be significantly differentially expressed by more than 1.2-fold between the two strains after multiple comparison adjustment using the false discovery rate method (FDR<0.05) were included in gene enrichment and pathway analyses, which were performed using Ingenuity Pathway Analysis software (application build 364062M, content version 26127183) as described previously (Krupkova et al. 2014 , Sedova et al. 2012 .
Results
Morphometry and basic metabolic profile
SHR-Dca rats weighted about 50 g less than SHR (Table 1) . Relative weights of visceral fat pad, kidney, and adrenals were significantly greater in SHR-Dca rats compared with SHR (Table 1) . Concentrations of fasting plasma glucose, insulin, leptin, adiponectin, and free glycerol as well as the liver triacylglycerol concentration were also comparable between SHR and SHR-Dca (Table 2 ). Fasting glucose concentrations as well as the courses of glycemic curves during the oral glucose tolerance test were nearly identical.
Detailed lipid profile
The distribution of triacylglycerols and cholesterol across major lipoprotein fractions followed a similar pattern in both strains except for HDL cholesterol concentrations, which were significantly lower in SHR-Dca compared with SHR ( Table 2 ). As shown in Fig. 1A , this difference was driven by distinct cholesterol content within very large and large HDL particles. Detailed comparison of triacylglycerol content in 20 lipoprotein fractions did not reveal any additional differences between SHR and SHR-Dca (Fig. 1B) Blood pressure measurements Throughout the 21-day period of measurement, SHR-Dca male rats showed significantly lower systolic (P<0.01; repeated measures ANOVA) and diastolic blood pressures (P<0.05; repeated measures ANOVA) compared with SHR (Fig. 2) . We observed similar differences in 6-months-old animals (data not shown). Heart rate comparison did not yield significant differences between the two strains throughout the whole period of measurement.
Insulin sensitivity of muscle and adipose tissues
Insulin sensitivity of visceral adipose tissue did not differ between SHR and SHR-Dca (Fig. 3A) . We observed reduced basal glycogenesis in muscles of SHR-Dca, but insulin-stimulated glycogenesis values were comparable between the strains (Fig. 3B) .
Immunohistochemical assessment of GJA8 tissue distribution
There were no differences in GJA8 expression or distribution between SHR and SHR-Dca. We were able to identify the presence of GJA8 in endothelium of large vessels including the aorta and vena cava, and in endothelium of capillaries in heart, lungs, liver, and kidneys. In glomeruli and pre-glomerular and peritubular capillaries, no staining was apparent in tubules (Fig. 4) . The basal membrane of the tubuli seminiferi in testes was also slightly positive. There were no morphological changes in renal parenchyma. The glomerular volume of SHR was significantly greater than that of SHR-Dca rats (4.44±0.25 vs. 3.39±0.28 × 10 6 µm 3 , P=0.013).
Heart and kidney transcriptome analysis
In heart, there were 303 transcripts showing >1.2-fold difference in expression between SHR and SHR-Dca, with 151 relatively upregulated and 152 downregulated in microphthalmic rats. The most enriched functional categories were related to cell development (Benjamini-Hochberg multiple testing correction; P=1.67 × 10 ), including the most significantly upregulated (S100A9, Csf3r, S100A8, Bcl6) and downregulated (Nr4a1, Fos, Egr1, Dusp1, Cyr61) genes in SHR-Dca compared with SHR. ) to be the top predicted upstream transcriptional regulators that can explain the observed gene expression changes in SHR-Dca vs. SHR hearts.
In the kidney, there were 487 transcripts showing >1.2-fold difference in expression between SHR and SHR-Dca, with 254 relatively upregulated and 233 downregulated in the microphthalmic rats. There were 21 transcripts common to the heart and kidney sets (Table 3) . We confirmed direction of expression changes between SHR and SHR-Dca by qPCR. Using all significantly differentially expressed genes, we systematically assessed their enrichment in ontological categories or disease-related gene sets as well as their potential functional connections. Gene set enrichment analysis revealed similar patterns as in the heart, with cellular growth and proliferation being the most enriched category (P=6.09 × 10 −9
). Interestingly, we observed concerted downregulation of cholesterol synthesis genes Dhcr7, Hmgcr, and Sqle, rendering the cholesterol biosynthesis the only significantly enriched tox list. The top predicted upstream transcriptional regulators in the kidney were colony stimulating factor 3 (P=1.79 × 10 ). Corresponding to findings in the heart, the canonical pathway of glial cell-derived neurotrophic factor family ligand-receptor interactions was significantly enriched (P=4.14 × 10 −2 ) and predicted to be inhibited in the kidney. The second enriched pathway was the role of macrophages, fibroblasts, and endothelial cells in rheumatoid arthritis (P=1.22 × 10 −2 ). We assessed potential functional relationships among genes differentially expressed between SHR and SHR-Dca both in the kidney and heart using dynamic pathway modeling. Both approaches focused on direct interactions of identified genes or the "shortest path" among them and revealed a network of tightly interconnected genes likely to represent the major module behind the Gja8-induced transcriptome shift (Fig. 5) .
Discussion
Conditions such as hypertension or diabetes have been previously associated with changes in regulation and expression of connexins 37, 40, 43, and 45 in a variety of tissues including heart (Meens et al. 2013 ), lungs (Kim et al. 2015 ), vasculature (Morton et al. 2015 , kidneys (Gerl et al. 2015) , and islets of Langerhans (Farnsworth and Benninger 2014). To date, connexin 50 has been almost exclusively associated with lens development .
Vol. 66 5 . Network analysis of the differentially expressed genes both in hearts and kidneys of SHR and SHR-Dca. The figure represents the network with the highest score (IPA, Ingenuity Systems) derived using the whole set of differentially expressed genes between SHR and SHR-Dca both in hearts and kidneys. Genes significantly downregulated in SHR-Dca compared with SHR in both hearts and kidneys are in red. Upregulated genes in SHR-Dca compared with SHR in both hearts and kidneys are in green. Grey shading denotes differential expression only in the heart or kidney. Blue lines represent known relationships between Gja8 and its closest neighbor members of the network. Grey lines denote known relationships among all the members of the network based on the Ingenuity Pathway Database.
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Gja8 mutations resulting in cataract and microphthalmia were described in mice (White et al. 1998 ), rats (Liska et al. 2008 ), and humans (Ge et al. 2014 , Shiels et al. 1998 . Interestingly, even transgenic overexpression of connexin 50 is reported to induce cataracts (Chung et al. 2007) . However, Gja8 expression is not limited to the lens, as shown in several studies including the present one. Localization of connexin 50 in vascular endothelial cells follows the pattern of predominant connexins (Gabriels and Paul 1998).
Besides the previously described microphthalmia and cataract development in SHR-Dca rats (Liska et al. 2008) , in the present study, we observed that a major effect of the L7Q mutation in the Gja8 gene was the lowering of blood pressure. In spite of the significant blood pressure decrease, the SHR-Dca rats still show values in hypertensive range. To date, several other connexins have been shown to modulate blood pressure in animal models. While Cx40-deficient mice are hypertensive, most likely because of renin cell displacement and defective pressure control of renin secretion, Cx37-knockout mice do not show changes in blood pressure (Figueroa and Duling 2008) , and endothelial cell-specific knockout of Cx43 (which is also significantly expressed in the lens) was shown to cause hypotension and bradycardia in mice (Liao et al. 2001 ). We did not observe any morphological changes suggestive of cardiac hypertrophy or kidney damage in spite of established hypertension. This may be because of the younger age of the rats used; enlarged glomeruli in SHR might indicate one of the stepping stones towards secondary focal segmental glomerulosclerosis through mechanical damage to podocytes (Kriz 2002) . Nevertheless, concerted expression changes in the heart suggest diverging paths between SHR and SHR-Dca, with a more favorable profile in Gja8-mutant rats.
Upregulation of several genes in SHR-Dca is indicative of a tendency towards decreased cardiac fibrosis including B-cell CLL/lymphoma 6, microRNAs miR-23, miR39, miR30, and let-7, nitric oxide synthase 3, cAMP responsive element binding protein 1, and cannabinoid receptor 2 genes (Ingenuity Knowledge Base).
One of the limitations of the present study lies in the fact that we did not uncover the detailed mechanism that results in the lowering of blood pressure and other metabolic effects in the Gja8-mutant animals. Analyses of the most perturbed pathways suggests several possible routes affecting a number of genes with a previously ascertained role in cardiovascular pathology, like S100 calcium binding protein A9 (Zhao et al. 2011) (Fig. 5) . SHR-Dca rats carry the nonsynonymous mutation L7Q in the amino terminal domain of Cx50 (Liska et al. 2008) . In a review of available structural and functional studies of Cx50 gap junction channels, Xin and Bai summarized compelling evidence that the amino terminal domain of Cx50 lines the pore of gap junction channels and plays an important role in single channel conductance and transjunctional voltage-dependent gating as well as in limiting the rate of ion permeation (Xin and Bai 2013). While we did not perform any functional studies, it is possible that the mutation in SHR-Dca's Cx50 changed its coupling properties resulting in altered vascular endothelial and smooth muscle cells communication.
We are aware that construction of mechanistic networks is based solely on available information on reported interactions between genes and their products; as such, it is inherently biased against the as yet uncharacterized or less annotated transcripts. Among the set of differentially expressed genes, we identified a number of microRNAs (11 and 15 in heart and kidney, respectively). The most upregulated microRNA in heart (and second most upregulated in kidney) of SHR-Dca compared with SHR was miR-223. Upregulation of miR-223 was found in the insulin-resistant human heart and its overexpression induced glucose transporter 4 protein expression (Lu et al. 2010) . This finding seems to be consistent with the decreased basal insulin sensitivity of skeletal muscle tissue in SHR-Dca. Also, miR-223 was found to regulate HDL cholesterol uptake and to inhibit cholesterol biosynthesis (Vickers et al. 2014) , again in line with findings from the comparison of the lipid profiles in the present study. Alternatively, downregulation of miR-223 in rat lungs is directly related to pathogenesis of the pulmonary artery hypertension (Meloche et al. 2015) , and elevated circulating miR-223 is a predictive biomarker of coronary artery disease and cardiovascular death (Schulte et al. 2015) .
Interestingly, the Gja8 gene is in an area of rat genome with numerous quantitative trait loci for blood pressure in SHR and other hypertensive rat models including Dahl salt-sensitive rat (Chauvet et al. 2013) or stroke-prone spontaneously hypertensive rat (Graham et al. 2007) . Therefore, variation in Gja8 gene might contribute to the respective QTLs, either acting alone or, in a modular, epistatic fashion (Chauvet et al. 2013 , Koh-Tan et al. 2013 . While it is unlikely that a second mutation (distinct from that in Gja8 gene) occurred in SHR-Dca and is responsible for the observed hemodynamic and metabolic effects, it cannot be ruled out absolutely. Potential genes of interest related to cardiovascular pathophysiology within the original interval that lead to identification of the causative Gja8 mutation include ATPase, Na+/K+ transporting, alpha 1 polypeptide (Herrera et al. 2015 , Orlov et al. 2001 , gap junction protein alpha 5 (Schmidt et al. 2015) , or thioredoxin-interacting protein (Yoshioka et al. 2012) .
In summary, we found that connexin 50 is expressed in vascular endothelium of a number of tissues.
Mutation L7Q in connexin 50 lowers blood pressure in the SHR-Dca strain and decreases HDL cholesterol and basal insulin sensitivity in skeletal muscle of the SHR.
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